Manufacturing / Pharmaceutical Preparations
Sarepta Therapeutics, Inc.
SRPT
$18.28
-$0.30 (-1.61%)
Price as of Nov 3, 2026 11:38 UTC
1.8 B
Market Cap (Small Cap)
44%
IV Rank
87.4%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 30
Bearish
0 of 7
Trend
- Above 20-day average $18.40
- Above 50-day average $18.55
- Above 200-day average $19.15 · -2.8%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 19d ago
Volume
- Below-average volume 0.5x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.98
Balanced
Implied Volatility
87.4%
1% percentile
IV vs Realized
Options rich
30d HV 58.7%
Options Heat Map
Delta-risk grid for SRPT options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
2 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Sep 04, 2026 | Rothfuss Cristin | Tax_withholding | 22,025 | $489,396 | -17.6% | |
| Sep 04, 2026 | Rodino-Klapac Louise | Tax_withholding | 21,423 | $476,019 | -17.6% | |
| Sep 04, 2026 | Wong Ryan Ho-Yan | Tax_withholding | 13,272 | $294,904 | -17.6% | |
| Sep 04, 2026 | Estepan Ian Michael | Tax_withholding | 24,799 | $551,034 | -17.6% | |
| Jul 28, 2026 | SEVERINO MICHAEL | Grant | 756,104 | $0 | +18.7% | |
| Jul 28, 2026 | SEVERINO MICHAEL | Grant | 2,224,342 | $0 | +18.7% | |
| Jun 04, 2026 | Wigzell Hans Lennart Rudolf | Grant | 16,875 | $0 | +10.0% | |
| Jun 04, 2026 | Wigzell Hans Lennart Rudolf | Other | 16,875 | $0 | +10.0% | |
| Jun 04, 2026 | Boor Kathryn Jean | Grant | 16,875 | $0 | +10.0% | |
| Jun 04, 2026 | Mayo Stephen | Grant | 16,875 | $0 | +10.0% |
Politician Trades in SRPT
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Apr 14, 2025 | Gil Cisneros | D | Sale | $1K-$15K | — |
| Jul 14, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K | -82.7% |
| Jun 13, 2023 | Josh S. Gottheimer | D | Sale | $1K-$15K | — |
| Apr 10, 2023 | Daniel Goldman | D | Sale | $15K-$50K | — |
| Mar 06, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K | -88.1% |
| Mar 06, 2023 | Daniel Goldman | D | Purchase | $15K-$50K | -88.1% |
| Jan 31, 2023 | Daniel Goldman | D | Sale | $1K-$15K | — |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Nov 02, 2026 | Q3 2026 | $0.09 | |||
| Aug 05, 2026 | Q2 2026 | $0.26 | |||
| Aug 04, 2026 | Q2 2026 | $0.27 | |||
| Jun 30, 2026 | Q2 2026 | $0.26 | $0.64 | +143.8% | Beat |
| Mar 31, 2026 | Q1 2026 | $1.01 | $2.88 | +184.7% | Beat |
| Dec 31, 2025 | Q4 2025 | -$1.26 | -$3.93 | -213.0% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.83 | -$0.01 | +98.8% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.77 | $1.89 | +146.8% | Beat |
Track SRPT with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SRPT and your entire portfolio.